Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,999 public trials 1,518 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors

NCT03343054

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • National Hospital Organization Hokkaido Cancer Center Sapporo, Hokkaido, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
View Trial Details
Completed

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy

NCT02743221

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Chris O'Brien Lifehouse Oncology Camperdown, Australia
  • Austin Hospital Olivia Newton-John Cancer & Wellness Centre Heidelberg, Australia
  • Western Health, Sunshine Hospital Saint Albans, Australia
  • The Queen Elizabeth Hospital Haematology and Oncology Unit Woodville, Australia
View all 57 locations
View Trial Details
Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

NCT02112656

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Toronto General Hospital Toronto, Ontario, Canada
  • Mengchao Hepatobiliary Hospital of Fujian Medicatl University Fuzhou, Fujian, China
  • Xijing Hospital Xi'an, Shaanxi, China
View all 61 locations
View Trial Details
Completed

Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment

NCT01863745

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kashiwa, Chiba, Japan
  • Novartis Investigative Site Gifu, Japan
  • Novartis Investigative Site Sapporo, Hokkaido, Japan
View Trial Details

Related conditions